HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corticosteroid therapy for duchenne muscular dystrophy: improvement of psychomotor function.

AbstractBACKGROUND:
Of the numerous clinical trials for Duchenne muscular dystrophy, only the corticosteroid prednisolone has shown potential for temporal improvement in motor ability. In this study, the effects of prednisolone on intellectual ability are examined in 29 cases of Duchenne muscular dystrophy because little information has been reported. And also, motor functions and cardiac functions were evaluated.
METHODS:
The treated group was administered prednisolone (0.75 mg/kg) orally on alternate days and the compared with the untreated control group. Gene mutations were investigated. The patients were examined for intelligence quotient adequate for age, brain natriuretic peptide, creatine kinase, and manual muscle testing before treatment and after the period 6 months to 2 years.
RESULTS:
Intelligence quotient scores of the treated increased to 6.5 ± 11.9 (mean ± standard deviation) were compared with the controls 2.1 ± 4.9 (P = 0.009). Intelligence quotient scores of the patients with nonsense point mutations improved significantly (21.0 ± 7.9) more than those with deletion or duplication (1.9 ± 9.0; P = 0.015). Motor function, such as time to stand up, of those treated improved significantly and brain natriuretic peptide level was reduced to a normal level after treatment in 15 patients (73%).
CONCLUSIONS:
Our results demonstrate the effectiveness of prednisolone in improving intellectual impairment as well as in preserving motor function and brain natriuretic peptide levels. We presume that prednisolone has a read-through effect on the stop codons in the central nervous systems of Duchenne muscular dystrophy because intelligence quotient of point mutation case was improved significantly.
AuthorsYuko Sato, Akemi Yamauchi, Mari Urano, Eri Kondo, Kayoko Saito
JournalPediatric neurology (Pediatr Neurol) Vol. 50 Issue 1 Pg. 31-7 (Jan 2014) ISSN: 1873-5150 [Electronic] United States
PMID24138948 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Adrenal Cortex Hormones
  • Natriuretic Peptide, Brain
  • Prednisolone
  • Creatine Kinase
  • prednylidene
Topics
  • Adrenal Cortex Hormones (therapeutic use)
  • Child
  • Child, Preschool
  • Creatine Kinase (blood)
  • Female
  • Humans
  • Intelligence Tests
  • Male
  • Muscle Strength (drug effects)
  • Muscular Dystrophy, Duchenne (complications, diagnosis, genetics)
  • Natriuretic Peptide, Brain (blood)
  • Prednisolone (analogs & derivatives, therapeutic use)
  • Psychomotor Agitation (drug therapy)
  • Psychomotor Disorders (drug therapy, etiology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: